Table 1.
Control group | Pregnant group | p value | |
---|---|---|---|
Mean + SE (µm) | Mean + SE (µm) | ||
T5 | 277.4 + 9.6 | 278.5 + 13.9 | 0.949 |
T4 | 284.8 + 10.1 | 291.5 + 15.2 | 0.716 |
T3 | 292.1 + 9.8 | 300.9 + 14.3 | 0.611 |
T2 | 301.7 + 8.9 | 308.2 + 14.8 | 0.708 |
T1 | 299.1 + 8.6 | 311.2 + 14.8 | 0.478 |
SF | 304.1 + 9.6 | 318.1 + 15.6 | 0.446 |
N1 | 285.1 + 9.6 | 291.3 + 14.9 | 0.730 |
N2 | 270.3 + 10.6 | 267.1 + 14.7 | 0.860 |
N3 | 245.6 + 10.9 | 239.4 + 13.9 | 0.725 |
N4 | 213.5 + 11.5 | 210.2 + 12.2 | 0.843 |
GEE with Bonferroni adjustment
T5: choroidal thickness at 2500 µm temporally to the fovea; T4: choroidal thickness at 2000 µm temporally to the fovea; T3: choroidal thickness at 1500 µm temporally to the fovea; T2: choroidal thickness at 1000 µm temporally to the fovea; T1: choroidal thickness at 500 µm temporally to the fovea; SF: choroidal thickness at the fovea; N1: choroidal thickness at 500 µm nasally to the fovea; N2: choroidal thickness at 1000 µm nasally to the fovea; N3: choroidal thickness at 1500 µm nasally to the fovea; N4: choroidal thickness at 2000 µm nasally to the fovea